HIV infection attacks the immune system. In many parts of Africa, patients with HIV infection, also have vitamin deficiencies. A new study examined whether giving a multivitamin and…
NEW YORK (Reuters Health) – In HIV patients with anal intraepithelial neoplasia (AIN), infrared coagulation (IRC) helps avoid progression to squamous cell carcinoma (SCC), Spanish doctors say. “High-grade…
NEW YORK (Reuters Health) – Outcomes among tuberculosis patients treated with a fixed-dose combination of four drugs are similar to those in patients treated with the same four…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the importance of taking a holistic approach to AIDS work in Africa. For more information…
NEW YORK (Reuters Health) – The presence of low-frequency HIV-1 drug resistance mutations – especially against non-nucleoside reverse transcriptase inhibitors (NNRTIs) – confers a greater than twofold increased…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses new Anti-AIDS drug treatments available, including Anti-AIDS gels and Anti-AIDS preventative drugs. For more information…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses relevant statistics regarding AIDS in Africa and elsewhere. For more information on ICAMiA’s important work…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses his work with the Israel Consortium on AIDS Medicine in Africa (ICAMiA) and the importance…
NEW YORK (Reuters Health) – People with HIV treated at outpatient clinics may be at an increased risk of bone fractures, according to a new study published in…
NEW YORK (Reuters Health) – Clinical practice guidelines on the management of hepatitis C infection, issued by the European Association for the Study of the Liver, underscore the…
NEW YORK (Reuters Health) — Chronically HIV-infected individuals show brain damage even when the disease is otherwise stable because of highly active antiretroviral therapy (HAART), according to a…
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine…
